Celanese Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.89 |
| EPS actual | $0.85 |
| EPS Surprise | -4.60% |
| Revenue estimate | 2.345B |
| Revenue actual | 2.337B |
| Revenue Surprise | -0.334% |
| Release date | Feb 17, 2026 |
| EPS estimate | $0.89 |
| EPS actual | $0.670 |
| EPS Surprise | -24.72% |
| Revenue estimate | 2.254B |
| Revenue actual | 2.204B |
| Revenue Surprise | -2.22% |
| Release date | Nov 06, 2025 |
| EPS estimate | $1.27 |
| EPS actual | $1.34 |
| EPS Surprise | 5.51% |
| Revenue estimate | 2.246B |
| Revenue actual | 2.419B |
| Revenue Surprise | 7.71% |
| Release date | Aug 11, 2025 |
| EPS estimate | $1.38 |
| EPS actual | $1.44 |
| EPS Surprise | 4.35% |
| Revenue estimate | 2.549B |
| Revenue actual | 2.532B |
| Revenue Surprise | -0.665% |
Last 4 Quarters for Celanese
Below you can see how CE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 11, 2025 |
| Price on release | $47.42 |
| EPS estimate | $1.38 |
| EPS actual | $1.44 |
| EPS surprise | 4.35% |
| Date | Price |
|---|---|
| Aug 05, 2025 | $49.35 |
| Aug 06, 2025 | $47.82 |
| Aug 07, 2025 | $48.65 |
| Aug 08, 2025 | $48.05 |
| Aug 11, 2025 | $47.42 |
| Aug 12, 2025 | $41.22 |
| Aug 13, 2025 | $41.80 |
| Aug 14, 2025 | $42.62 |
| Aug 15, 2025 | $42.48 |
| 4 days before | -3.91% |
| 4 days after | -10.42% |
| On release day | -13.07% |
| Change in period | -13.92% |
| Release date | Nov 06, 2025 |
| Price on release | $36.11 |
| EPS estimate | $1.27 |
| EPS actual | $1.34 |
| EPS surprise | 5.51% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $38.44 |
| Nov 03, 2025 | $37.06 |
| Nov 04, 2025 | $37.34 |
| Nov 05, 2025 | $36.94 |
| Nov 06, 2025 | $36.11 |
| Nov 07, 2025 | $41.30 |
| Nov 10, 2025 | $41.30 |
| Nov 11, 2025 | $41.40 |
| Nov 12, 2025 | $39.12 |
| 4 days before | -6.06% |
| 4 days after | 8.34% |
| On release day | 14.37% |
| Change in period | 1.77% |
| Release date | Feb 17, 2026 |
| Price on release | $55.71 |
| EPS estimate | $0.89 |
| EPS actual | $0.670 |
| EPS surprise | -24.72% |
| Date | Price |
|---|---|
| Feb 10, 2026 | $58.32 |
| Feb 11, 2026 | $60.56 |
| Feb 12, 2026 | $58.82 |
| Feb 13, 2026 | $58.85 |
| Feb 17, 2026 | $55.71 |
| Feb 18, 2026 | $54.86 |
| Feb 19, 2026 | $54.92 |
| Feb 20, 2026 | $54.11 |
| Feb 23, 2026 | $52.34 |
| 4 days before | -4.48% |
| 4 days after | -6.05% |
| On release day | -1.53% |
| Change in period | -10.25% |
| Release date | May 05, 2026 |
| Price on release | $69.00 |
| EPS estimate | $0.89 |
| EPS actual | $0.85 |
| EPS surprise | -4.60% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $65.09 |
| Apr 30, 2026 | $67.76 |
| May 01, 2026 | $69.24 |
| May 04, 2026 | $68.74 |
| May 05, 2026 | $69.00 |
| May 06, 2026 | $62.12 |
| May 07, 2026 | $58.40 |
| May 08, 2026 | $57.17 |
| May 11, 2026 | $59.55 |
| 4 days before | 6.01% |
| 4 days after | -13.70% |
| On release day | -9.97% |
| Change in period | -8.51% |
Celanese Earnings Call Transcript Summary of Q1 2026
Celanese remains focused on cash generation and positioning the business to be resilient amid weak end-market demand and regional supply-chain disruptions. Management guided to approximately $3 of EPS contribution in the back half of 2026 based on a base-case scenario where supply chains begin to unwind by the end of Q2 and moderate through H2; they emphasized scenario-based flexibility and the ability to pivot operating rates (e.g., Clear Lake, Frankfurt) to capture upside or protect margins. The acetyl chain is driving near-term improvement (weighted to the Western Hemisphere and downstream VAM/vinyls/products), but prices and margins are regionally uneven (China saw a spike then moderation). Engineered Materials (EM) is being “fortified”: restructuring and asset repositioning (including nylon polymer capacity changes) target roughly $30 million of incremental annual cost savings (about one-third to flow in 2026 with <1-year payback). Management expects an additional ~$50 million of absorption headwind in EM in H2 (some coming from drawing transition nylon inventory), plus Q2 turnaround costs (~$15M), which the company expects to mostly offset via volume gains and pricing. Working capital will moderate cash flow timing (roughly half of incremental EBITDA conversion to cash in 2026 with some balance into 2027), and M&A remains active though market conditions have slowed deal activity. Key near-term risks include further supply-chain disruption, raw-material inflation, demand weakness or prebuying dynamics, and regional price divergence in acetyl-related markets.
Sign In
Buy CE